The pending sale of Pfizer’s Little Island and Loughbeg plants in Cork, Ireland did not go through, according to a company statement, leaving 480 jobs at risk. The potential buyer withdrew its offer, citing that the facility does not meet its requirements. The sale of the plants, which made APIs for Pfizer drugs, was announced in February 2007 after the cholesterol drug torcetrapib failed in clinical trials. The Cork plants were slated to produce almost 40% of torcetrapib’s active ingredie...